Aldeyra The (137)

Frankfurt
Currency in EUR
2.3280
-0.0820(-3.40%)
Delayed Data·
137 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
Day's Range
2.32802.3280
52 wk Range
1.30206.4160
Key Statistics
Edit
Bid/Ask
2.327 / 2.397
Prev. Close
2.41
Open
2.328
Day's Range
2.328-2.328
52 wk Range
1.302-6.416
Volume
-
Average Volume (3m)
1.6K
1-Year Change
-33.74%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
137 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Significant return over the last week
Show more

Aldeyra The Company Profile

Aldeyra Therapeutics, Inc., a biotechnology company, discovers and develops therapies designed to treat immune-mediated and metabolic diseases. Its lead product candidate is reproxalap, a reactive aldehyde species (RASP) modulator, which is in Phase III clinical trial for the treatment of dry eye disease and allergic conjunctivitis; and ADX-2191, a dihydrofolate reductase inhibitor for the treatment retinitis pigmentosa. The company also develops ADX-629, an orally administered RASP modulator that is in Phase 2 clinical trials for the treatment of COVID-19, atopic asthma, psoriasis, and alcohol intoxication. In addition, it develops preclinical RASP platform, including ADX 248, ADX 743, ADX 631, ADX 246, and other product candidates in development for inflammatory and metabolic diseases. The company was formerly known as Aldexa Therapeutics, Inc. and changed its name to Aldeyra Therapeutics, Inc. in March 2014. Aldeyra Therapeutics, Inc. was incorporated in 2004 and is based in Lexington, Massachusetts.

Compare 137 to Peers and Sector

Metrics to compare
137
Peers
Sector
Relationship
P/E Ratio
−2.9x−0.3x−0.5x
PEG Ratio
0.060.020.00
Price/Book
2.3x1.9x2.6x
Price / LTM Sales
-12.0x2.9x
Upside (Analyst Target)
-191.8%56.4%
Fair Value Upside
Unlock12.8%9.3%Unlock

Earnings

Latest Release
Feb 28, 2025
EPS / Forecast
-0.27 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

People Also Watch

6.050
MLGO
-14.91%
11.140
HOLO
-2.62%
8.60
LUNR
+0.35%
17.4000
TNXP
+2.17%
7.000
QBTS
-5.02%

FAQ

What Is the Aldeyra The (137) Stock Price Today?

The Aldeyra The stock price today is 2.33

What Stock Exchange Does Aldeyra The Trade On?

Aldeyra The is listed and trades on the Frankfurt Stock Exchange stock exchange.

What Is the Stock Symbol for Aldeyra The?

The stock symbol for Aldeyra The is "137."

What Is the Aldeyra The Market Cap?

As of today, Aldeyra The market cap is 141.28M.

What is Aldeyra The Earnings Per Share?

The Aldeyra The EPS is -0.94.

From a Technical Analysis Perspective, Is 137 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.